How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

CellCarta and Pillar Biosciences Accelerate FGFR NGS Assay from RUO to IUO for Global Phase 3 Oncology Trial

calendar_today June 23, 2026 person Katrina McCullough domain pillar-biosciences

Integrated collaboration completed clinical trial assay development and validation and enabled IDE and associated regulatory submissions in approximately five to six months. MONTREAL, CANADA, – June 23, 2026 – CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced the successful development and clinical implementation of a customized FGFR next-generation sequencing assay in collaboration […]

open_in_new Read original post